基本信息
浏览量:31
![](https://originalfileserver.aminer.cn/sys/aminer/icon/show-trajectory.png)
个人简介
Dr. Deborah Pajalunga graduated from University “Sapienza” (Rome, Italy) in Biological Sciences and completed her student training period characterizing the peroxisomal proliferators adverse effects on kidney and liver of treated rats. She acquired the Specialty Degree in Clinical Pathology at the same University. Dr. Pajalunga was a postdoctoral fellow at Regina Elena Cancer Institute (Rome, Italy), where she focused her studies on the E2F regulation and functions in postmitotic cells. In 2001, she became a postdoctoral fellow at the National Cancer Institute-FCRDC (NIH, Frederick, U.S.A), where she studied the HGF- and VEGF-mediated oncogenic signaling. She is currently a Senior Researcher at the Higher Institute of Health (Rome, Italy). Throughout her scientific career, Dr. Pajalunga studied and characterized the cell cycle regulation of terminally differentiated cells and their potential application in regenerative medicine. Dr. Pajalunga was awarded an Italian Ministry of Health Grant, a FIRC Fellowship for Cancer Research abroad, three years FIRC Fellowship, and three years Adriano Buzzati-Traverso Foundation Fellowship. Dr. Pajalunga conducts reviewer activity for PubMed-indexed journals.
研究兴趣
论文共 28 篇作者统计合作学者相似作者
按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
Deborah Pajalunga,Elisa Franzolin, Martina Stevanoni, Sara Zribi,Nunzia Passaro,Aymone Gurtner,Samantha Donsante, Daniela Loffredo, Lidia Losanno,Vera Bianchi,Antonella Russo,Chiara Rampazzo,
Cancer cellno. 2 (2012): 250-62
加载更多
作者统计
合作学者
合作机构
D-Core
- 合作者
- 学生
- 导师
数据免责声明
页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果,我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问,可以通过电子邮件方式联系我们:report@aminer.cn